scispace - formally typeset
Open AccessJournal ArticleDOI

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

TLDR
A model for the genomic alterations associated with meningioma progression is proposed on the basis of the most common aberrations identified in the various malignancy grades.
Abstract
Nineteen benign [World Health Organization (WHO) grade I; MI], 21 atypical (WHO grade II; MII), and 19 anaplastic (WHO grade III; MIII) sporadic meningiomas were screened for chromosomal imbalances by comparative genomic hybridization (CGH). These data were supplemented by molecular genetic analyses of selected chromosomal regions and genes. With increasing malignancy grade, a marked accumulation of genomic aberrations was observed; i.e., the numbers (mean +/- SEM) of total alterations detected per tumor were 2.9 +/- 0.7 for MI, 9.2 +/- 1.2 for MII, and 13.3 +/- 1.9 for MIII. The most frequent alteration detected in MI was loss on 22q (58%). In MII, aberrations most commonly identified were losses on 1p (76%), 22q (71%), 14q (43%), 18q (43%), 10 (38%), and 6q (33%), as well as gains on 20q (48%), 12q (43%), 15q (43%), 1q (33%), 9q (33%), and 17q (33%). In MIII, most of these alterations were found at similar frequencies. However, an increase in losses on 6q (53%), 10 (68%), and 14q (63%) was observed. In addition, 32% of MIII demonstrated loss on 9p. Homozygous deletions in the CDKN2A gene at 9p21 were found in 4 of 16 MIII (25%). Highly amplified DNA sequences were mapped to 12q13-q15 by CGH in 1 MII. Southern blot analysis of this tumor revealed amplification of CDK4 and MDM2. By CGH, DNA sequences from 17q were found to be amplified in 1 MII and 8 MIII, involving 17q23 in all cases. Despite the high frequency of chromosomal aberrations in the MII and MIII investigated, none of these tumors showed mutations in exons 5-8 of the TP53 gene. On the basis of the most common aberrations identified in the various malignancy grades, a model for the genomic alterations associated with meningioma progression is proposed.

read more

Citations
More filters
Journal ArticleDOI

The WHO Classification of Tumors of the Nervous System

TL;DR: The new World Health Organization (WHO) classification of nervous system tumors, published in 2000, emerged from a 1999 international consensus conference of neuropathologists, and new entities include chordoid glioma of the third ventricle, cerebellar liponeurocytoma, atypical teratoid/rhabdoid tumor, and perineurioma.
Journal ArticleDOI

Commentary on the WHO Classification of Tumors of the Nervous System

TL;DR: The new World Health Organization (WHO) classification of nervous system tumors, published in 2000, emerged from a 1999 international consensus conference of neuropathologists, and new entities include chordoid glioma of the third ventricle, cerebellar liponeurocytoma, atypical teratoid/rhabdoid tumor, and perineurioma.
Journal ArticleDOI

"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

TL;DR: In this article, the authors expanded their analysis to include 116 patients diagnosed with malignant meningioma due to brain invasion, frank anaplasia (20 mitoses per 10 high power fields or histology resembling carcinoma, sarcoma, or melanoma), and/or extracranial metastasis.
Journal ArticleDOI

Histological classification and molecular genetics of meningiomas.

TL;DR: The most common genetic alterations associated with the initiation of meningiomas are mutations in the NF2 gene and loss of chromosome 22q as mentioned in this paper, however, most of the relevant genes are yet to be identified.
Journal ArticleDOI

A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells

TL;DR: The data suggest that MEG3 may represent a novel growth suppressor, which may play an important role in the development of human pituitary adenomas, which are the most common intracranial neoplasm in humans.
References
More filters
Journal ArticleDOI

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

TL;DR: Amplification of the HER-2/neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer, and had greater prognostic value than most currently used prognostic factors in lymph node-positive disease.
Journal ArticleDOI

A genetic model for colorectal tumorigenesis

TL;DR: A model for the genetic basis of colorectal neoplasia that includes the following salient features is presented, which may be applicable to other common epithelial neoplasms, in which tumors of varying stage are more difficult to study.
Journal ArticleDOI

Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors

TL;DR: Comparative genomic hybridization produces a map of DNA sequence copy number as a function of chromosomal location throughout the entire genome, which identified 16 different regions of amplification, many in loci not previously known to be amplified.
Related Papers (5)